SBC Medical Group Holdings Inc (SBC) stock

SBCNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as SBCWW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 12/3039% below fair value

$5.34+0.10 (+1.91%)

Close on Nov 12, 2026Market cap $549.20MP/E 11.4Yield –

SBC Medical statistics

95 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Nov 13, 2026 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $549.20M; $1.69B
Enterprise Value: $380.87M; $2.21B
PE Ratio: 11.36; 23.82
PS Ratio: 3.14; 1.54
PB Ratio: 2.08; 3.43
P/TBV Ratio: 2.71; 5.80
P/FCF Ratio: 8.89; 20.54
P/OCF Ratio: 8.74; 14.89

Enterprise valuationIndustry

EV / Sales: 2.17; 1.67
EV / EBITDA: 5.55; 15.40
EV / EBIT: 5.82; 20.39
EV / FCF: 6.17; 24.39

Share statisticsIndustry

Shares Outstanding: 103M; 59M
Shares Change (YoY): 1.42%; 2.40%
Shares Change (QoQ): 0.00%; 0.33%
Float: 19M; 35M
Shares Held by Insiders: 82.0%; 15.2%
Shares Held by Institutions: 8.32%; 83.6%

Short sellingIndustry

Short Interest: 840,714; –
Short Interest Change: 12.0%; -0.86%
Days to Cover: 4.57; 4.41

Stock price statisticsIndustry

52-Week High: $5.79; –
52-Week Low: $2.78; –
20-Day Moving Average: $5.33; –
50-Day Moving Average: $5.07; –
200-Day Moving Average: $3.95; –
Average True Range (14): $0.25; –
Price Change (1 Week): 6.37%; -0.16%
Price Change (1 Month): 2.10%; 0.10%
Price Change (3 Months): 45.9%; 1.86%
Price Change (6 Months): 79.2%; 15.1%
Price Change (YTD): 23.9%; 5.96%
Price Change (1 Year): 57.1%; 8.30%
Price Change (3 Years): -49.8%; 20.9%
Average Volume (10 Days): 192,745; –
Average Volume (20 Days): 190,995; –
Average Volume (90 Days): 170,496; –
Relative Volume: 1.19; 0.77
Relative Strength Index (14): 53.5; 46.5
Volatility (1 Year): 55.3%; 63.0%
Beta (5 Years): 0.45; 0.77

MarginsIndustry

Gross Margin: 71.9%; 33.3%
Operating Margin: 37.3%; -2.98%
Pretax Margin: 43.1%; 2.12%
Profit Margin: 28.0%; -2.01%
EBITDA Margin: 39.2%; 3.36%
FCF Margin: 35.3%; 2.98%

Returns on capitalIndustry

Return on Equity (ROE): 19.3%; 4.82%
Return on Assets (ROA): 13.6%; -3.06%
Return on Invested Capital (ROIC): 50.7%; 4.69%
Return on Capital Employed (ROCE): 19.9%; 0.40%

Financial positionIndustry

Current Ratio: 3.31; 1.41
Quick Ratio: 2.35; 0.99
Debt / Equity: 0.00; 0.69
Debt / EBITDA: 0.00; 2.57
Debt / FCF: 0.00; 4.04
Net Debt / EBITDA: -2.69; 2.14
Interest Coverage: 194.92; -0.63

GrowthIndustry

Revenue Growth (YoY): -6.92%; 9.63%
Net Income Growth (YoY): 47.1%; 16.5%
EPS Growth (YoY): 46.9%; 19.0%

EfficiencyIndustry

Asset Turnover: 0.49; 0.81
Inventory Turnover: 21.05; 10.99
Revenue Per Employee: $202.98K; $235.26K
Profits Per Employee: $56.81K; -$5.12K
Employee Count: 863; 910
WACC: 7.38%; 8.16%

Income statement (TTM)Industry

Revenue: $175.17M; $638.13M
Gross Profit: $125.86M; $196.31M
Operating Income: $65.41M; -$675.66K
Pretax Income: $75.49M; -$575.82K
Net Income: $49.03M; -$1.48M
EBITDA: $68.63M; $1.43M
EPS (Diluted): $0.47; -$0.02

Balance sheetIndustry

Cash & Short-Term Investments: $184.62M; $98.48M
Total Debt: $203.51K; $246.10M
Net Cash (Debt): $184.42M; $119.40K
Net Cash Per Share: $1.79; $0.00
Equity (Book Value): $263.84M; $235.60M
Book Value Per Share: $2.57; $3.91
Tangible Book Value: $202.97M; $1.59M
Working Capital: $180.93M; $30.06M

Cash flow (TTM)Industry

Operating Cash Flow: $62.82M; $25.90M
Capital Expenditures: -$1.05M; -$15.83M
Free Cash Flow: $61.77M; $18.83M
FCF Per Share: $0.60; $0.36

Dividends and yieldsIndustry

Earnings Yield: 8.93%; 0.25%
FCF Yield: 11.2%; 2.58%

Taxes and interestIndustry

Interest Expense: $335.57K; $7.37M
Income Tax: $25.31M; $564.50K
Effective Tax Rate: 33.5%; 24.1%

Scores and fair valueIndustry

Graham Number: $5.21; $21.25
Graham Upside: -2.46%; -49.9%
Altman Z-Score: 5.00; 2.24
Piotroski F-Score: 4; 5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	SBC	S&P 500	Difference	SBC per year	S&P 500 per year
1 month	-0.9%	-2.7%	+1.8 pts
3 months	+66.9%	-1.7%	+68.6 pts
Year to date	+23.9%	+11.9%	+12.0 pts
1 year	+58.0%	+12.0%	+46.0 pts
3 years	-49.8%	+78.2%	−127.9 pts	-20.5%	+21.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M SBC shares were sold short on Oct 30, 2026, up 12.0% from the previous report. At recent volumes it would take 4.6 days to buy them back. Over the last 20 sessions, 52.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	840,714	+12.0%	184,147	4.6
Oct 15, 2026	750,813	-7.8%	192,228	3.9
Sep 30, 2026	813,900	+13.4%	241,834	3.4
Sep 15, 2026	717,532	+3.1%	176,871	4.1
Aug 31, 2026	696,167	+3.2%	203,197	3.4
Aug 14, 2026	674,547	-17.1%	144,961	4.7
Jul 31, 2026	814,023	-11.0%	67,098	12.1
Jul 15, 2026	914,813	+66.6%	93,798	9.8
Jun 30, 2026	549,171	+45.4%	203,860	2.7
Jun 15, 2026	377,572	-2.9%	103,770	3.6
May 29, 2026	388,650	+42.1%	137,490	2.8
May 15, 2026	273,445	-12.4%	129,472	2.1